Dr Samuel Joseph Mease, MD | |
4745 Ogletown Stanton Rd Ste 225, Newark, DE 19713-1387 | |
(302) 731-2888 | |
Not Available |
Full Name | Dr Samuel Joseph Mease |
---|---|
Gender | Male |
Speciality | Student In An Organized Health Care Education/training Program |
Location | 4745 Ogletown Stanton Rd Ste 225, Newark, Delaware |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1346624681 | NPI | - | NPPES |
Entity Name | First State Orthopaedics Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1346220266 PECOS PAC ID: 6103800057 Enrollment ID: O20040617000139 |
News Archive
Researchers at the University of Pittsburgh School of Medicine have developed a mouse model of major depressive disorder (MDD) that is based on a rare genetic mutation that appears to cause MDD in the majority of people who inherit it.
Although tumor metastasis causes about 90 percent of cancer deaths, the exact mechanism that allows cancer cells to spread from one part of the body to another is not well understood. One key question is how tumor cells detach from the structural elements that normally hold tissues in place, then reattach themselves in a new site.
Adding a fifth link to the "Chain of Survival" concept for management of patients with out-of-hospital cardiac arrest significantly improves their survival and positive neurologic outcome chances, a study suggests.
BioDefense Therapeutics—a Joint Product Management office within the U.S. Department of Defense—announced the first patient enrolled in the North American Phase 3 clinical trials for favipiravir (T-705a). The drug is an investigational flu treatment candidate with broad-spectrum potential being developed by BD Tx through a contract with Boston-based MediVector, Inc.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Samuel Joseph Mease, MD 4745 Ogletown Stanton Rd Ste 225, Newark, DE 19713-1387 Ph: (302) 731-2888 | Dr Samuel Joseph Mease, MD 4745 Ogletown Stanton Rd Ste 225, Newark, DE 19713-1387 Ph: (302) 731-2888 |
News Archive
Researchers at the University of Pittsburgh School of Medicine have developed a mouse model of major depressive disorder (MDD) that is based on a rare genetic mutation that appears to cause MDD in the majority of people who inherit it.
Although tumor metastasis causes about 90 percent of cancer deaths, the exact mechanism that allows cancer cells to spread from one part of the body to another is not well understood. One key question is how tumor cells detach from the structural elements that normally hold tissues in place, then reattach themselves in a new site.
Adding a fifth link to the "Chain of Survival" concept for management of patients with out-of-hospital cardiac arrest significantly improves their survival and positive neurologic outcome chances, a study suggests.
BioDefense Therapeutics—a Joint Product Management office within the U.S. Department of Defense—announced the first patient enrolled in the North American Phase 3 clinical trials for favipiravir (T-705a). The drug is an investigational flu treatment candidate with broad-spectrum potential being developed by BD Tx through a contract with Boston-based MediVector, Inc.
› Verified 2 days ago